(S)-2-(4-(4-(4-(5-(1-amino-1-(4-fluorophenyl)ethyl)pyrimidin-2-yl)piperazin-1-yl)pyrrolo[2,1-f][1,2,4]triazin-6-yl)-1H-pyrazol-1-yl)ethan-1-ol - CAS:2505078-08-8

Tel : 0086-021-5165-9050 / 0086-15618223367 Email : sales@atkchmemical.com

(S)-2-(4-(4-(4-(5-(1-amino-1-(4-fluorophenyl)ethyl)pyrimidin-2-yl)piperazin-1-yl)pyrrolo[2,1-f][1,2,4]triazin-6-yl)-1H-pyrazol-1-yl)ethan-1-ol

Catalog NO.: ATK-20742

Purity: 98.00%

CAS No.: 2505078-08-8

Molecular formula: C27H29FN10O

Molecular weight: 528.583966970444

Article number	Size	Operate
ATK-20742 10MG	10MG	Inquiry
ATK-20742 25MG	25MG	Inquiry

Bulk Inquiry

Detection information

Select batch:

Purity: 99.99%

COA

HPLC

NMR

SDS

Product Details

CAS Number	2505078-08-8	Appearance
Catalog NO	ATK-20742	MDL Number
Molecular Formula	C27H29FN10O	Molecular Weight	528.583966970444
Boiling Point		Melting Point
Flash Poin		Density
Synonyms	Elenestinib;Elenestinib [USAN];6FBM4CP6RK;(S)-2-(4-(4-(4-(5-(1-amino-1-(4-fluorophenyl)ethyl)pyrimidin-2-yl)piperazin-1-yl)pyrrolo(2,1-f)(1,2,4)triazin-6-yl)-1H-pyrazol-1-yl)ethan-1-ol;(S)-2-(4-(4-(4-(5-(1-amino-1-(4-fluorophenyl)ethyl)pyrimidin-2-yl)piperazin-1-yl)pyrrolo[2,1-f][1,2,4]triazin-6-yl)-1H-pyrazol-1-yl)ethan-1-ol;1H-Pyrazole-1-ethanol, 4-(4-(4-(5-((1S)-1-amino-1-(4-fluorophenyl)ethyl)-2-pyrimidinyl)-1-piperazinyl)pyrrolo(2,1-f)(1,2,4)triazin-6-yl)-;1H-Pyrazole-1;BLU-263;BLU 263;1H-Pyrazole-1-ethanol, 4-[4-[4-[5-[(1S)-1-amino-1-(4-fluorophenyl)ethyl]-2-pyrimidinyl]-1-piperazinyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl]-;2-{4-[4-(4-{5-[(1S)-1-amino-1-(4-fluorophenyl)ethyl]pyrimidin-2-yl}piperazin-1-yl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]-1H-pyrazol-1-yl}ethan-1-ol;D12450;GLXC-26842;EX-A4620;UNII-6FBM4CP6RK;4-[4-[4-[5-[(1S)-1-Amino-1-(4-fluorophenyl)ethyl]-2-pyrimidinyl]-1-piperazinyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl]-1H-pyrazole-1-ethanol;KIT D816V Mutant-selective Inhibitor BLU-263;2-(4-(4-(4-(5-((1S)-1-amino-1-(4-fluorophenyl)ethyl)pyrimidin-2-yl)piperazin-1-yl)pyrrolo(2,1-f)(1,2,4)triazin-6-yl)pyrazol-1-yl)ethanol;CS-0641116;Blu263;Elenestinib(BLU-263);2505078-08-8;2-{4-[4-(4-{5-[(1S)-1-amino-1-(4- fluorophenyl)ethyl]pyrimidin-2-yl}piperazin-1- yl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]-1H-pyrazol-1- yl}ethan-1-ol;SCHEMBL22527434;AT32812;4-(4-(4-(5-((1S)-1-Amino-1-(4-fluorophenyl)ethyl)-2-pyrimidinyl)-1-piperazinyl)pyrrolo(2,1-f)(1,2,4)triazin-6-yl)-1H-pyrazole-1-ethanol;exampl4 4 (WO2020210293A1);AC-37128;CHEMBL5314552;exampl4 4 [WO2020210293A1];2-[4-[4-[4-[5-[(1S)-1-amino-1-(4-fluorophenyl)ethyl]pyrimidin-2-yl]piperazin-1-yl]pyrrolo[2,1-f][1,2,4]triazin-6-yl]pyrazol-1-yl]ethanol;Elenestinib (USAN);elenestinib [INN];D816V-mutant KIT Inhibitor BLU-263;MS-29783;HY-152839;GTPL12357;WHO 12608;DA-73060;2-(4-(4-(4-(5-((1S)-1-amino-1-(4-fluorophenyl)ethyl)pyrimidin-2-yl)piperazin-1-yl)pyrrolo(2,1-f)(1,2,4)triazin-6-yl)-1H-pyrazol-1-yl)ethan-1-ol
Storage Condition

Safety

GHS Pictogram
Signal Word		UN Number
Hazard Statements		Class
Precautionary Statements		Packing Group

Description

There is currently no product overview available！